Balance Sheet NEC Corporation

Equities

6701

JP3733000008

IT Services & Consulting

Market Closed - Japan Exchange Other stock markets 12:00:00 10/04/2026 pm IST			5-day change	1st Jan Change
3,860.00 ^JPY	-4.64%		-4.60%	-27.31%

07:22am	SoftBank has set up a company in Japan to develop AI domestically, Nikkei says	RE
03/04	Transgene, NEC Bio Enter Partnership to Develop Cancer Vaccine	MT

fef0534fa522a2fac8bfe.1LKJjuK8J_Su3g8lYUyjoQh2_SBV3s3IVAjY_MFXYR4.luPb77LkYM3pk2BtCwXA9GA4yVQ3qPSuZXnpm5RnNHCEyO2-s-tevsCUaA

Published financial data: NEC CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	2,99400Cr	3,01400Cr	3,31300Cr	3,47700Cr	3,42300Cr
Total Revenues	2,99400Cr	3,01400Cr	3,31300Cr	3,47700Cr	3,42300Cr
Cost of Goods Sold, Total	2,13300Cr	2,12800Cr	2,35500Cr	2,47100Cr	2,36300Cr
Gross Profit	86TCr	89TCr	96TCr	1,00600Cr	1,06100Cr
Selling General & Admin Expenses, Total	73TCr	76TCr	79TCr	81TCr	78TCr
R&D Expenses	-	-	-	-	-
Other Operating Expenses	-2.56TCr	-908.2Cr	-589.9Cr	383.3Cr	2.66TCr
Other Operating Expenses, Total	71TCr	75TCr	79TCr	82TCr	80TCr
Operating Income	16TCr	13TCr	17TCr	19TCr	26TCr
Interest Expense, Total	-1.06TCr	-803.2Cr	-800.1Cr	-1.22TCr	-946.4Cr
Interest And Investment Income	969.1Cr	580.6Cr	697.9Cr	892Cr	964Cr
Net Interest Expenses	-92Cr	-222.6Cr	-102.2Cr	-323.2Cr	18Cr
Income (Loss) On Equity Invest.	499.4Cr	538.4Cr	394.9Cr	526.7Cr	-1.01TCr
Currency Exchange Gains (Loss)	-	201.9Cr	-415.8Cr	-259.6Cr	-286Cr
Other Non Operating Income (Expenses)	-	-300.4Cr	218.5Cr	-244Cr	-393.9Cr
EBT, Excl. Unusual Items	16TCr	13TCr	17TCr	19TCr	24TCr
Restructuring Charges	-	-	-	-	-
Merger & Related Restructuring Charges	-129.8Cr	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	973.8Cr	-373Cr	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Insurance Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	16TCr	14TCr	17TCr	19TCr	24TCr
Income Tax Expense	-403.5Cr	-1.23TCr	3.62TCr	2.03TCr	5.51TCr
Earnings From Continuing Operations	16TCr	16TCr	13TCr	16TCr	18TCr
Net Income to Company	16TCr	16TCr	13TCr	16TCr	18TCr
Minority Interest	-1.23TCr	-1.54TCr	-1.7TCr	-1.52TCr	-948.1Cr
Net Income - (IS)	15TCr	14TCr	11TCr	15TCr	18TCr
Net Income to Common Incl Extra Items	15TCr	14TCr	11TCr	15TCr	18TCr
Net Income to Common Excl. Extra Items	15TCr	14TCr	11TCr	15TCr	18TCr
Per Share Items
Net EPS - Basic	111.44	103.71	84.9	112.25	131.5
Basic EPS - Continuing Operations	111.44	103.71	84.9	112.25	131.5
Basic Weighted Average Shares Outstanding	134.25Cr	136.22Cr	134.86Cr	133.2Cr	133.22Cr
Net EPS - Diluted	111.44	103.71	84.9	112.25	131.49
Diluted EPS - Continuing Operations	111.44	103.71	84.9	112.25	131.49
Diluted Weighted Average Shares Outstanding	134.25Cr	136.22Cr	134.86Cr	133.2Cr	133.22Cr
Normalized Basic EPS	64.95	50.48	66.82	75.37	105.37
Normalized Diluted EPS	64.95	50.48	66.82	75.37	105.37
Dividend Per Share	18	20	22	24	28
Payout Ratio	14.23	19.29	24.91	20.5	19.8
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	32TCr	31TCr	35TCr	38TCr	41TCr
EBITA	16TCr	13TCr	17TCr	19TCr	26TCr
EBIT	16TCr	13TCr	17TCr	19TCr	26TCr
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	-2.56	-8.49	21.56	10.95	22.98
Total Current Taxes	-	-	-	-	-
Total Deferred Taxes	-	-	-	-	-
Normalized Net Income	8.72TCr	6.88TCr	9.01TCr	10TCr	14TCr
Non-Cash Pension Expense	-	56Cr	-4.4Cr	60Cr	-264.8Cr
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	-	13TCr	12TCr	12TCr	9.92TCr
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	-	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	52TCr	43TCr	42TCr	48TCr	58TCr
Short Term Investments	957.3Cr	-	-	-	-
Total Cash And Short Term Investments	53TCr	43TCr	42TCr	48TCr	58TCr
Accounts Receivable, Total	1,01100Cr	72TCr	80TCr	83TCr	88TCr
Other Receivables	-	-	-	-	-
Total Receivables	1,01100Cr	72TCr	80TCr	83TCr	88TCr
Inventory	19TCr	25TCr	27TCr	24TCr	18TCr
Prepaid Expenses	-	5.97TCr	6.66TCr	6.87TCr	7.85TCr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	13TCr	38TCr	44TCr	52TCr	50TCr
Total Current Assets	1,86100Cr	1,83700Cr	1,99600Cr	2,14200Cr	2,22500Cr
Gross Property Plant And Equipment	1,52300Cr	-	-	-	-
Accumulated Depreciation	-97TCr	-	-	-	-
Net Property Plant And Equipment	55TCr	54TCr	56TCr	51TCr	58TCr
Long-term Investments	28TCr	52TCr	53TCr	65TCr	59TCr
Goodwill	30TCr	34TCr	36TCr	39TCr	39TCr
Other Intangibles, Total	37TCr	37TCr	38TCr	37TCr	35TCr
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	13TCr	15TCr	16TCr	16TCr	18TCr
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	17TCr	-	-	-	-
Total Assets	3,66900Cr	3,76200Cr	3,98400Cr	4,22800Cr	4,31500Cr
Liabilities
Accounts Payable, Total	47TCr	45TCr	50TCr	52TCr	49TCr
Accrued Expenses, Total	22TCr	23TCr	24TCr	25TCr	25TCr
Short-term Borrowings	-	8.22TCr	4.42TCr	2.46TCr	16TCr
Current Portion of Long-Term Debt	5.15TCr	10TCr	8.67TCr	6.01TCr	7.45TCr
Current Portion of Leases	4.75TCr	4.95TCr	4.71TCr	5.26TCr	5.25TCr
Current Income Taxes Payable	2.81TCr	5.47TCr	6.38TCr	7.61TCr	11TCr
Unearned Revenue Current, Total	25TCr	-	-	-	-
Other Current Liabilities	14TCr	36TCr	39TCr	48TCr	48TCr
Total Current Liabilities	1,19800Cr	1,33400Cr	1,36600Cr	1,46900Cr	1,62700Cr
Long-Term Debt	49TCr	26TCr	32TCr	30TCr	26TCr
Long-Term Leases	12TCr	10TCr	11TCr	11TCr	12TCr
Pension & Other Post Retirement Benefits	19TCr	18TCr	18TCr	16TCr	14TCr
Deferred Tax Liability Non Current	-	4.48TCr	4.46TCr	3.71TCr	3.21TCr
Other Non Current Liabilities	11TCr	5.56TCr	5.15TCr	6.24TCr	6.7TCr
Total Liabilities	2,10700Cr	1,97500Cr	2,07100Cr	2,13800Cr	2,24400Cr
Common Stock, Total	43TCr	43TCr	43TCr	43TCr	43TCr
Additional Paid In Capital	17TCr	17TCr	17TCr	17TCr	4.67TCr
Retained Earnings	56TCr	68TCr	76TCr	88TCr	1,02400Cr
Treasury Stock	-157.8Cr	-190.6Cr	-3.16TCr	-3.11TCr	-3.07TCr
Comprehensive Income and Other	15TCr	24TCr	30TCr	47TCr	48TCr
Total Common Equity	1,30800Cr	1,51400Cr	1,62400Cr	1,91600Cr	1,95200Cr
Minority Interest	25TCr	27TCr	29TCr	17TCr	12TCr
Total Equity	1,56200Cr	1,78700Cr	1,91300Cr	2,09000Cr	2,07200Cr
Total Liabilities And Equity	3,66900Cr	3,76200Cr	3,98400Cr	4,22800Cr	4,31500Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	136.25Cr	136.23Cr	133.17Cr	133.23Cr	133.45Cr
ECS Total Common Shares Outstanding	136.25Cr	136.23Cr	133.17Cr	133.23Cr	133.27Cr
Book Value / Share	960.13	1.11T	1.22T	1.44T	1.46T
Tangible Book Value	64TCr	80TCr	89TCr	1,15200Cr	1,20600Cr
Tangible Book Value Per Share	468.83	589.32	668.29	864.36	905.11
Total Debt	70TCr	60TCr	61TCr	55TCr	67TCr
Net Debt	17TCr	17TCr	19TCr	7.22TCr	8.17TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	-	1.83TCr	-1.53TCr	-13TCr	-8.92TCr
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	25TCr	27TCr	29TCr	17TCr	12TCr
Equity Method Investments, Total	7.33TCr	7.65TCr	8.04TCr	11TCr	11TCr
Account Code - Inventory Valuation	8	-	-	-	-
Inventories - Raw Materials, Total	-	8.68TCr	9.55TCr	7.98TCr	6.15TCr
Inventories - Work In Process, Total	-	7.57TCr	8.3TCr	6.52TCr	5.84TCr
Inventories - Finished Goods, Total	-	8.37TCr	8.91TCr	9.76TCr	6.49TCr
Land - (BS)	-	-	-	-	-
Buildings, Total	-	-	-	-	-
Machinery, Total	-	-	-	-	-
Full Time Employees	1L	1L	1L	1L	1L
Part Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	580.4Cr	-	-	-	-

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	15TCr	14TCr	17TCr	19TCr	24TCr
Depreciation & Amortization - CF	17TCr	18TCr	18TCr	19TCr	16TCr
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	17TCr	18TCr	18TCr	19TCr	16TCr
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	98Cr	685.7Cr	473.5Cr	959Cr
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	403.5Cr	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-499.4Cr	-538.4Cr	-394.9Cr	-526.7Cr	1.01TCr
Other Operating Activities, Total	-7.42TCr	-4.91TCr	-3.14TCr	-4.62TCr	-4.03TCr
Change In Accounts Receivable	-1.6TCr	2.55TCr	-7.73TCr	-6.48TCr	-5.58TCr
Change In Inventories	1.92TCr	-5.88TCr	-2.34TCr	-665.8Cr	5.27TCr
Change In Accounts Payable	492.6Cr	-2.74TCr	4.11TCr	2.42TCr	-1.26TCr
Change in Unearned Revenues	2.47TCr	-	-	-	-
Change in Other Net Operating Assets	-	-6.31TCr	-11TCr	-752.9Cr	-1.76TCr
Cash from Operations	27TCr	15TCr	15TCr	27TCr	34TCr
Capital Expenditure	-5.93TCr	-5.69TCr	-5.64TCr	-7.52TCr	-13TCr
Sale of Property, Plant, and Equipment	4.18TCr	1.54TCr	1.24TCr	765.6Cr	870.1Cr
Cash Acquisitions	-20TCr	-1.24TCr	-713.3Cr	-108.7Cr	-667.3Cr
Divestitures	557.5Cr	718.3Cr	1.16TCr	-689Cr	1.54TCr
Sale (Purchase) of Intangible assets	-1.16TCr	-1.42TCr	-2.13TCr	-2.46TCr	-2.42TCr
Investment in Marketable and Equity Securities, Total	10TCr	676.4Cr	1.71TCr	1.63TCr	159Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	99Cr	-924Cr	-584.9Cr	776.4Cr	46Cr
Cash from Investing	-12TCr	-6.34TCr	-4.96TCr	-7.6TCr	-13TCr
Short Term Debt Issued, Total	-	3.87TCr	-	-	13TCr
Long-Term Debt Issued, Total	13TCr	38Cr	15TCr	4TCr	3.2TCr
Total Debt Issued	13TCr	3.91TCr	15TCr	4TCr	17TCr
Short Term Debt Repaid, Total	-4.73TCr	-	-4TCr	-2.13TCr	-
Long-Term Debt Repaid, Total	-16TCr	-14TCr	-10TCr	-8.67TCr	-6.12TCr
Total Debt Repaid	-20TCr	-14TCr	-14TCr	-11TCr	-6.12TCr
Issuance of Common Stock	6.41TCr	24Cr	86Cr	57Cr	47Cr
Repurchase of Common Stock	-	-	-3.05TCr	-7.4Cr	-
Common Dividends Paid	-2.13TCr	-2.73TCr	-2.85TCr	-3.07TCr	-3.47TCr
Common & Preferred Stock Dividends Paid	-2.13TCr	-2.73TCr	-2.85TCr	-3.07TCr	-3.47TCr
Other Financing Activities, Total	2.82TCr	-6.4TCr	-7.01TCr	-5.73TCr	-17TCr
Cash from Financing	139.4Cr	-19TCr	-12TCr	-16TCr	-10TCr
Foreign Exchange Rate Adjustments	612.2Cr	1.29TCr	893.4Cr	1.73TCr	-114.5Cr
Miscellaneous Cash Flow Adjustments	416.1Cr	-	-	-	-
Net Change in Cash	16TCr	-9.26TCr	-1.13TCr	5.7TCr	11TCr
Supplemental Items
Cash Interest Paid	781.3Cr	850.8Cr	741.8Cr	1.1TCr	909.8Cr
Cash Income Tax Paid (Refund)	2.45TCr	4TCr	3.74TCr	5.27TCr	4.71TCr
Levered Free Cash Flow	27TCr	11TCr	13TCr	25TCr	20TCr
Unlevered Free Cash Flow	28TCr	11TCr	13TCr	26TCr	20TCr
Change In Net Working Capital	-8.49TCr	7.88TCr	8.07TCr	-5.57TCr	-3.33TCr
Net Debt Issued / Repaid	-6.97TCr	-9.86TCr	547.2Cr	-6.8TCr	10TCr

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.85	2.23	2.75	2.86	3.75
Return on Total Capital	4.78	3.56	4.34	4.56	5.96
Return On Equity %	12.1	9.36	7.11	8.23	8.88
Return on Common Equity	13.49	10.01	7.3	8.45	9.06
Margin Analysis
Gross Profit Margin %	28.76	29.41	28.92	28.93	30.98
SG&A Margin	24.44	25.31	23.96	23.41	22.71
EBITDA Margin %	10.78	10.39	10.68	10.8	12.12
EBITA Margin %	5.18	4.4	5.14	5.41	7.49
EBIT Margin %	5.18	4.4	5.14	5.41	7.49
Income From Continuing Operations Margin %	5.41	5.2	3.97	4.74	5.39
Net Income Margin %	5	4.69	3.46	4.3	5.12
Net Avail. For Common Margin %	5	4.69	3.46	4.3	5.12
Normalized Net Income Margin	2.91	2.28	2.72	2.89	4.1
Levered Free Cash Flow Margin	9.08	3.6	3.82	7.29	5.71
Unlevered Free Cash Flow Margin	9.3	3.76	3.97	7.51	5.88
Asset Turnover
Asset Turnover	0.88	0.81	0.86	0.85	0.8
Fixed Assets Turnover	5.39	5.51	6	6.47	6.27
Receivables Turnover (Average Receivables)	3.06	3.55	4.35	4.27	4.01
Inventory Turnover (Average Inventory)	11.08	9.86	9.17	9.69	11.06
Short Term Liquidity
Current Ratio	1.55	1.38	1.46	1.46	1.37
Quick Ratio	1.29	0.86	0.89	0.89	0.9
Operating Cash Flow to Current Liabilities	0.23	0.11	0.11	0.18	0.21
Days Sales Outstanding (Average Receivables)	119.16	102.82	83.85	85.75	91.05
Days Outstanding Inventory (Average Inventory)	32.93	37.04	39.82	37.78	33.01
Average Days Payable Outstanding	75.04	72.22	72.54	76.1	80.17
Cash Conversion Cycle (Average Days)	77.05	67.63	51.14	47.43	43.89
Long Term Solvency
Total Debt/Equity	45	33.44	31.81	26.26	32.17
Total Debt / Total Capital	31.04	25.06	24.13	20.8	24.34
LT Debt/Equity	38.66	20.21	22.51	19.69	18.34
Long-Term Debt / Total Capital	26.66	15.15	17.08	15.59	13.88
Total Liabilities / Total Assets	57.43	52.5	51.99	50.57	52
EBIT / Interest Expense	14.61	16.5	21.3	15.47	27.1
EBITDA / Interest Expense	30.4	38.98	44.21	30.92	43.84
(EBITDA - Capex) / Interest Expense	24.82	31.89	37.16	24.73	30.49
Total Debt / EBITDA	2.18	1.91	1.72	1.46	1.61
Net Debt / EBITDA	0.53	0.53	0.53	0.19	0.2
Total Debt / (EBITDA - Capex)	2.67	2.33	2.05	1.83	2.31
Net Debt / (EBITDA - Capex)	0.65	0.65	0.64	0.24	0.28
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.27	0.67	9.92	4.96	-1.55
Gross Profit, 1 Yr. Growth %	-2.97	2.93	8.1	4.97	5.44
EBITDA, 1 Yr. Growth %	66.81	64.88	12.99	6.21	10.44
EBITA, 1 Yr. Growth %	5.75	-9.84	28.61	10.31	36.43
EBIT, 1 Yr. Growth %	16.97	2.35	28.61	10.31	36.43
Earnings From Cont. Operations, 1 Yr. Growth %	43.6	-3.19	-16.07	25.27	12.09
Net Income, 1 Yr. Growth %	49.66	-5.57	-18.95	30.59	17.16
Normalized Net Income, 1 Yr. Growth %	28.72	-0.5	31.05	11.42	39.82
Diluted EPS Before Extra, 1 Yr. Growth %	44.72	-6.94	-18.13	32.21	17.14
Accounts Receivable, 1 Yr. Growth %	7.07	-25.98	10.73	3.7	5.9
Inventory, 1 Yr. Growth %	-6.91	32.71	8.66	-9.32	-23.84
Net Property, Plant and Equip., 1 Yr. Growth %	-0.88	-2.33	4.28	-9.3	13.54
Total Assets, 1 Yr. Growth %	17.46	2.54	5.91	6.11	2.08
Tangible Book Value, 1 Yr. Growth %	16.06	22.17	10.86	29.39	4.75
Common Equity, 1 Yr. Growth %	43.65	15.7	7.29	17.97	1.9
Cash From Operations, 1 Yr. Growth %	4.98	-46.34	3.12	78.29	26.98
Capital Expenditures, 1 Yr. Growth %	-18.56	-3.98	-0.98	33.31	68.15
Levered Free Cash Flow, 1 Yr. Growth %	39.81	-57.86	16.56	100.53	-22.89
Unlevered Free Cash Flow, 1 Yr. Growth %	38.83	-56.8	15.81	98.68	-22.86
Dividend Per Share, 1 Yr. Growth %	28.57	11.11	10	9.09	16.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.37	-1.32	5.19	7.41	1.65
Gross Profit, 2 Yr. CAGR %	1.87	-0.06	5.49	6.52	5.2
EBITDA, 2 Yr. CAGR %	49.52	27.8	36.49	9.55	8.3
EBITA, 2 Yr. CAGR %	25.25	-4.36	7.69	19.11	22.67
EBIT, 2 Yr. CAGR %	30.06	0.66	14.74	19.11	22.67
Earnings From Cont. Operations, 2 Yr. CAGR %	76.55	17.91	-9.86	2.54	18.5
Net Income, 2 Yr. CAGR %	94.19	18.88	-12.52	2.88	23.69
Normalized Net Income, 2 Yr. CAGR %	32.91	1.58	14.19	20.84	24.81
Diluted EPS Before Extra, 2 Yr. CAGR %	90.99	16.05	-12.71	4.04	24.45
Accounts Receivable, 2 Yr. CAGR %	3.01	-12.53	-9.46	7.16	4.8
Inventory, 2 Yr. CAGR %	-11.07	11.15	20.09	-0.74	-16.9
Net Property, Plant and Equip., 2 Yr. CAGR %	16.32	-1.61	0.92	-2.75	1.48
Total Assets, 2 Yr. CAGR %	11.27	9.75	4.21	6.01	4.08
Tangible Book Value, 2 Yr. CAGR %	15.65	20.78	16.38	19.77	16.42
Common Equity, 2 Yr. CAGR %	23.41	28.92	11.41	12.5	9.64
Cash From Operations, 2 Yr. CAGR %	106.87	-24.94	-25.61	35.6	50.46
Capital Expenditures, 2 Yr. CAGR %	10.1	-11.57	-2.49	14.89	49.72
Levered Free Cash Flow, 2 Yr. CAGR %	63.13	-25.11	-29.91	52.89	24.35
Unlevered Free Cash Flow, 2 Yr. CAGR %	61.74	-24.58	-29.27	51.69	23.8
Dividend Per Share, 2 Yr. CAGR %	50	19.52	10.55	9.54	12.82
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.72	1.14	2.29	5.11	4.34
Gross Profit, 3 Yr. CAGR %	2.59	2.22	2.59	5.31	6.16
EBITDA, 3 Yr. CAGR %	24.67	29.45	22.66	25.54	9.85
EBITA, 3 Yr. CAGR %	30.06	10.27	5.57	8.55	24.62
EBIT, 3 Yr. CAGR %	30.06	13.08	9.23	13.24	24.62
Earnings From Cont. Operations, 3 Yr. CAGR %	39.09	44.51	5.28	0.59	5.63
Net Income, 3 Yr. CAGR %	48.3	52.7	4.63	-0.02	7.43
Normalized Net Income, 3 Yr. CAGR %	42.51	11.68	10.58	13.26	26.86
Diluted EPS Before Extra, 3 Yr. CAGR %	46.69	50.29	3.31	0.24	8.23
Accounts Receivable, 3 Yr. CAGR %	4.73	-8.81	-5.37	-5.27	6.74
Inventory, 3 Yr. CAGR %	-5.56	1.62	10.31	9.35	-9.13
Net Property, Plant and Equip., 3 Yr. CAGR %	11.45	9.74	0.32	-2.61	2.4
Total Assets, 3 Yr. CAGR %	9.15	8.28	8.45	4.84	4.68
Tangible Book Value, 3 Yr. CAGR %	-0.6	18.9	17.38	20.56	14.53
Common Equity, 3 Yr. CAGR %	14.09	20.78	21.26	13.56	8.85
Cash From Operations, 3 Yr. CAGR %	28.36	31.93	-16.56	-0.45	32.66
Capital Expenditures, 3 Yr. CAGR %	11.1	5.19	-8.17	8.22	30.45
Levered Free Cash Flow, 3 Yr. CAGR %	-	2.01	-13.21	-0.5	21.7
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	2.15	-12.99	-0.2	21.08
Dividend Per Share, 3 Yr. CAGR %	14.47	35.72	16.26	10.06	11.87
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.2	2.49	3.1	3.6	2.04
Gross Profit, 5 Yr. CAGR %	0.44	3.24	3.74	3.92	3.63
EBITDA, 5 Yr. CAGR %	12.34	18.76	16.26	21.09	16.7
EBITA, 5 Yr. CAGR %	7.64	18.38	19.32	13.72	12.1
EBIT, 5 Yr. CAGR %	7.64	20.51	19.32	15.45	14.42
Earnings From Cont. Operations, 5 Yr. CAGR %	16.93	34.79	16.93	25.97	10.38
Net Income, 5 Yr. CAGR %	16.83	38.92	20.08	30.39	11.87
Normalized Net Income, 5 Yr. CAGR %	11.35	26.83	24.5	15.26	16.07
Diluted EPS Before Extra, 5 Yr. CAGR %	16.06	37.61	19.18	29.73	11.3
Accounts Receivable, 5 Yr. CAGR %	3.1	-5.38	-1.89	-2.73	-1.43
Inventory, 5 Yr. CAGR %	-4.04	3.65	3.97	0.67	-1.5
Net Property, Plant and Equip., 5 Yr. CAGR %	10.76	5.21	7.11	4.56	0.78
Total Assets, 5 Yr. CAGR %	8.03	6.98	7.15	7.37	6.68
Tangible Book Value, 5 Yr. CAGR %	0.14	4.35	6.47	19.25	16.99
Common Equity, 5 Yr. CAGR %	10.55	12.12	13.01	17.4	16.47
Cash From Operations, 5 Yr. CAGR %	22.95	9.78	3.2	33.39	5.63
Capital Expenditures, 5 Yr. CAGR %	14.78	8.89	5.45	8.97	11.66
Levered Free Cash Flow, 5 Yr. CAGR %	28.12	-6.68	4.12	19.93	0.22
Unlevered Free Cash Flow, 5 Yr. CAGR %	26.83	-6.56	4.14	19.66	0.19
Dividend Per Share, 5 Yr. CAGR %	8.45	10.76	12.89	24.57	14.87